RWJMS: Appointments of Drs. Wondisford and Radovick
February 10, 2015
Dear RBHS Community:
Interim Dean Vicente Gracias and I are pleased to announce the appointment of two outstanding physician scientists to leadership positions in the Rutgers Robert Wood Johnson Medical School.
Fredric E. Wondisford, MD, has been named professor of medicine and chair of medicine at Rutgers Robert Wood Johnson Medical School and chief of the department of medicine at Robert Wood Johnson University Hospital. Sally Radovick, MD, has been named professor of pediatrics and senior associate dean for clinical and translational research at Rutgers Robert Wood Johnson Medical School. We are also pleased to announce that both Dr. Wondisford and Dr. Radovick will be Chancellor Scholars, a new designation awarded by the Rutgers Biomedical and Health Sciences to our academically strongest new recruits.
Dr. Wondisford served as professor of medicine, pediatrics and physiology and as director of the metabolism division at Johns Hopkins University School of Medicine. He also served as director of the Johns Hopkins Diabetes Institute, leading a multi-disciplinary effort of research scientists and physicians to improve the quality of care for patients. His well-funded research program focuses on pituitary and pancreatic hormonal growth and regulation. He is the inventor of the approach to synthesize recombinant human TSH, for which he holds two U.S. patents. Recombinant human TSH (Thyrogen) is FDA-approved for use in the diagnosis and treatment of patients with thyroid cancer.
Dr. Radovick served as the Lawson Wilkins Professor of Pediatrics, director of the division of endocrinology, and vice chair for research in the department of pediatrics at Johns Hopkins University School of Medicine. An expert in pediatric growth and development disorders, Dr. Radovick’s well-funded research program focuses on steroids that control sexual maturity and reproduction, neurotransmitters, and growth factors. In addition, she studies the deficiency of hormones produced by the pituitary gland in children with growth failure.
Both Dr. Wondisford and Dr. Radovick are members of the American Association of Physicians and the American Society for Clinical Investigation. Please join us in welcoming Dr. Wondisford and Dr. Radovick to Rutgers University. This is a great example of our strength as the newly integrated Rutgers to recruit international talent and another step forward in building for the State of New Jersey one of the best academic health centers in the country.
Brian L. Strom, MD, MPH
Chancellor, Rutgers Biomedical & Health Sciences
Vicente H. Gracias, MD
Dean (Interim) Robert Wood Johnson Medical School